Helmholtz Institute for Biomedical Engineering, Biointerface Lab, RWTH Aachen University Hospital, Aachen, Germany.
Helmholtz Institute for Biomedical Engineering, Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen, Germany.
PLoS One. 2020 Feb 19;15(2):e0228503. doi: 10.1371/journal.pone.0228503. eCollection 2020.
The plasma protein fetuin-A mediates the formation of protein-mineral colloids known as calciprotein particles (CPP)-rapid clearance of these CPP by the reticuloendothelial system prevents errant mineral precipitation and therefore pathological mineralization (calcification). The mutant mouse strain D2,Ahsg-/- combines fetuin-A deficiency with the calcification-prone DBA/2 genetic background, having a particularly severe compound phenotype of microvascular and soft tissue calcification. Here we studied mechanisms leading to soft tissue calcification, organ damage and death in these mice. We analyzed mice longitudinally by echocardiography, X-ray-computed tomography, analytical electron microscopy, histology, mass spectrometry proteomics, and genome-wide microarray-based expression analyses of D2 wildtype and Ahsg-/- mice. Fetuin-A-deficient mice had calcified lesions in myocardium, lung, brown adipose tissue, reproductive organs, spleen, pancreas, kidney and the skin, associated with reduced growth, cardiac output and premature death. Importantly, early-stage calcified lesions presented in the lumen of the microvasculature suggesting precipitation of mineral containing complexes from the fluid phase of blood. Genome-wide expression analysis of calcified lesions and surrounding (not calcified) tissue, together with morphological observations, indicated that the calcification was not associated with osteochondrogenic cell differentiation, but rather with thrombosis and fibrosis. Collectively, these results demonstrate that soft tissue calcification can start by intravascular mineral deposition causing microvasculopathy, which impacts on growth, organ function and survival. Our study underscores the importance of fetuin-A and related systemic regulators of calcified matrix metabolism to prevent cardiovascular disease, especially in dysregulated mineral homeostasis.
血浆蛋白胎球蛋白 A 介导形成蛋白-矿物质胶体,称为钙磷蛋白颗粒 (CPP) - 网状内皮系统快速清除这些 CPP 可防止异常矿物质沉淀,从而防止病理性矿化(钙化)。突变鼠种 D2,Ahsg-/- 结合了胎球蛋白 A 缺乏和易钙化的 DBA/2 遗传背景,具有微血管和软组织钙化的特别严重的复合表型。在这里,我们研究了导致这些小鼠软组织钙化、器官损伤和死亡的机制。我们通过超声心动图、X 射线计算机断层扫描、分析电子显微镜、组织学、质谱蛋白质组学以及 D2 野生型和 Ahsg-/- 小鼠的全基因组微阵列表达分析对小鼠进行了纵向分析。胎球蛋白 A 缺乏的小鼠在心肌、肺、棕色脂肪组织、生殖器官、脾脏、胰腺、肾脏和皮肤中出现钙化病变,伴有生长不良、心输出量减少和过早死亡。重要的是,早期钙化病变出现在微血管腔中,表明含有矿物质的复合物从血液的液相中沉淀出来。钙化病变和周围(未钙化)组织的全基因组表达分析以及形态学观察表明,钙化与骨软骨生成细胞分化无关,而是与血栓形成和纤维化有关。总的来说,这些结果表明,软组织钙化可以通过血管内矿物质沉积引起微血管病开始,这会影响生长、器官功能和存活。我们的研究强调了胎球蛋白 A 和相关的全身性钙化基质代谢调节剂对预防心血管疾病的重要性,特别是在矿物质稳态失调的情况下。